Phospholipid involvement in the interaction of abused drugs with neural membranes.
D000818:Animals; D001514:Bee Venoms; D002118:Calcium / Q000494:pharmacology; D002262:Carboxy-Lyases / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism; D002462:Cell Membrane / Q000502:physiology*; D010450:Endopeptidases / Q000494:pharmacology; D005231:Fatty Acids, Unsaturated / Q000502:physiology; D013287:Illicit Drugs / Q000378:metabolism*; D009020:Morphine / Q000378:metabolism; D009474:Neurons / Q000502:physiology; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D010718:Phosphatidylserines / Q000502:physiology*; D010740:Phospholipases / Q000378:metabolism; D011950:Receptors, Cholinergic / Q000378:metabolism*; D011976:Receptors, Muscarinic / Q000187:drug effects / Q000378:metabolism*; D011957:Receptors, Opioid / Q000187:drug effects / Q000378:metabolism*; D013499:Surface Properties; D013574:Synaptosomes / Q000187:drug effects; D013816:Thermodynamics
D001514:Bee Venoms; D002395:Catecholamines; D005231:Fatty Acids, Unsaturated; D013287:Illicit Drugs; D004364:Pharmaceutical Preparations; D010718:Phosphatidylserines; D011950:Receptors, Cholinergic; D011976:Receptors, Muscarinic; D011957:Receptors, Opioid; D009020:Morphine; D010740:Phospholipases; D010450:Endopeptidases; D002262:Carboxy-Lyases; D002118:Calcium